MoneyWorks4Me

The revenue for the March 2023 quarter is pegged at Rs. 351.99 millions, about 24.42% up against Rs. 282.90 millions recorded during the year-ago period.Net profit surges 84.28% to Rs. 63.54  millions  from Rs. 34.48 millions in the quarter ended March 2023.Operating Profit saw a handsome growth to 87.54 millions from 59.30 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 351.99 282.90 24.42 1367.49 1239.80 10.30 1367.49 1239.80 10.30
Other Income 12.56 12.78 -1.72 51.23 49.49 3.52 51.23 49.49 3.52
PBIDT 87.54 59.30 47.62 354.90 322.04 10.20 354.90 322.04 10.20
Interest 0.84 1.21 -30.58 3.67 4.35 -15.63 3.67 4.35 -15.63
PBDT 86.70 58.09 49.25 351.23 317.69 10.56 351.23 317.69 10.56
Depreciation 5.94 5.38 10.41 22.59 18.99 18.96 22.59 18.99 18.96
PBT 80.76 52.71 53.22 328.64 298.70 10.02 328.64 298.70 10.02
TAX 17.22 18.23 -5.54 82.58 75.74 9.03 82.58 75.74 9.03
Deferred Tax 1.62 4.73 -65.75 -2.25 2.96 -176.01 -2.25 2.96 -176.01
PAT 63.54 34.48 84.28 246.06 222.96 10.36 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 24.87 20.96 18.65 25.95 25.98 -0.09 25.95 25.98 -0.09
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..